Immunochem
Corroy-le-Grand, Belgium · immunochem.be
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Immunochem is a Belgian biotech company in Corroy-le-Grand that designs antibodies, nanobodies, miniprotein binders and peptides by computation and validates them in the lab. It serves clients needing binder discovery, antibody engineering and optimization services, with a focus on developable candidates from antigen sequence or existing sequences.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody discovery
Designs developable antibodies against a chosen epitope from an antigen sequence, in formats including IgG, Fab, scFv and VHH.
Nanobody (VHH) discovery
Designs single-domain antibodies against the exact site the client wants to engage, without immunisation or display libraries.
Miniprotein binder discovery
Designs small, cheap-to-express binders for targets where an antibody scaffold is not needed.
Peptide discovery
Designs peptides for small sites, known blocking interactions, or initial epitope mapping, then makes and tests them.
Antibody humanization
Moves antibody frameworks toward human germlines while retaining residues that carry the binding site.
Developability optimization
Evaluates and re-engineers candidates to address liabilities that could affect formulation or development.
Cross-reactivity design
Designs binders to bind the species needed for a preclinical package while avoiding unwanted paralogues.
Affinity maturation
Models the interface and ranks substitutions to improve binding without a display campaign.
AI antibody generation from antigen sequence
Uses AI and computational design to generate candidate binders from an antigen sequence, with wet-lab validation.
Binder redesign from reference sequences
Designs around an existing antibody sequence to increase diversity, developability or support freedom-to-operate analysis.
Optimization of existing antibody candidates
Checks developability, specificity, yield and thermostability before scale-up.
What they work on
- Modalities
- Small molecule, Antibody, Peptide
- Species and models
- human germlines, llama
- Assays and studies
- binding, wet-lab validation, SPR
- Instruments and platforms
- SPR
- Scale and capacity
- 50 to 200 candidates, 6 stages, 9 weeks to binders validated in the laboratory
- Turnaround
- Free verdict in about 3 business days · candidate sequences in 6 weeks · wet-lab validated in 9 weeks · Week 7-9 wet-lab validation
- What to send
- Send your antigen sequence. · Antigen sequence or structure. · Reference sequence of your antibody. · Information about existing antibody candidates and objective.
- Sites
- Corroy-le-Grand, Belgium
- Founded
- 1998
Similar labs. CDI Labs, Bioklone Biotech Private Limited, Creative Biolabs, Sparx BIO
Found in a contract services directory. Listing built from immunochem.be. Work here? Claim this listing.